We are live on ! Find out more
GHDX

Genomic Health, Inc.
GHDX

Delisted

GHDX was delisted on the 7th of November, 2019.

Back to rankings

115 hedge funds and large institutions have $858M invested in Genomic Health, Inc. in 2013 Q2 according to their latest regulatory filings, with 115 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

55% less call options, than puts

Call options by funds: $2.69M | Put options by funds: $6M

Holders
115
Holders Change
+115
Holders Change %
–
% of All Funds
3.75%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
115
Increased
–
Reduced
–
Closed
–
Calls
$2.69M
Puts
$6M
Net Calls
-$3.31M
Net Calls Change
-$3.31M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Deutsche Bank
26
Deutsche Bank
Germany
$3.22M +$3.34M +101,587 New
MAA
27
Managed Account Advisors
New Jersey
$3.02M +$3.13M +95,294 New
Bank of New York Mellon
28
Bank of New York Mellon
New York
$2.9M +$3.01M +91,519 New
Two Sigma Investments
29
Two Sigma Investments
New York
$2.85M +$2.95M +89,912 New
Geode Capital Management
30
Geode Capital Management
Massachusetts
$2.56M +$2.66M +80,881 New
Citadel Advisors
31
Citadel Advisors
Florida
$2.54M +$2.64M +80,253 New
CS
32
Credit Suisse
Switzerland
$2.48M +$2.56M +78,090 New
GC
33
Guggenheim Capital
Illinois
$2.29M +$2.37M +72,263 New
BWFA
34
Baltimore-Washington Financial Advisors
Maryland
$2.1M +$2.17M +66,135 New
SI
35
Scout Investments
Missouri
$2.05M +$2.13M +64,750 New
Wellington Management Group
36
Wellington Management Group
Massachusetts
$2.04M +$2.11M +64,237 New
QI
37
Quotient Investors
New York
$1.91M +$1.98M +60,300 New
Bank of America
38
Bank of America
North Carolina
$1.69M +$1.75M +53,257 New
CWM
39
Cabot Wealth Management
Massachusetts
$1.55M +$1.6M +48,797 New
AllianceBernstein
40
AllianceBernstein
Tennessee
$1.45M +$1.51M +45,847 New
IG
41
ING Group
Netherlands
$1.44M +$1.48M +45,072 New
BIM
42
BlackRock Investment Management
Delaware
$1.4M +$1.45M +44,087 New
Charles Schwab
43
Charles Schwab
California
$1.38M +$1.38M +42,097 New
State Board of Administration of Florida Retirement System
44
State Board of Administration of Florida Retirement System
Florida
$1.26M +$1.31M +39,798 New
OC
45
Oppenheimer & Co
New York
$1.14M +$1.18M +35,985 New
California Public Employees Retirement System
46
California Public Employees Retirement System
California
$1.11M +$1.15M +34,915 New
KB
47
Kimelman & Baird
New York
$1.08M +$1.12M +34,100 New
RA
48
Royce & Associates
New York
$1.05M +$1.08M +33,000 New
GCP
49
GSA Capital Partners
United Kingdom
$997K +$1.03M +31,432 New
Allianz Asset Management
50
Allianz Asset Management
Germany
$926K +$959K +29,200 New
1
2
3 4 5

GHDX Hedge Fund Activity: Q2 2013 in Review

115 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in Genomic Health, Inc. (GHDX) for Q2 2013, worth a combined $858M.

Buyers outnumbered sellers: 115 funds opened new GHDX positions and 0 closed out — a net gain of 115 holders — while 0 added to existing stakes and 0 trimmed.

  • 115 institutional investors held Genomic Health, Inc. (GHDX) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $858M of Genomic Health, Inc. stock for Q2 2013.
  • 115 funds opened new Genomic Health, Inc. positions in Q2 2013 and 0 closed out, a net change of +115 holders.

Based on aggregated 13F filings for Q2 2013.